- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02232009
Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly)
Development of MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth - 1 month) and infants (>1 month to two years), such as clinical neonatal intensive care units (NICUs) and other infant and neonatal care departments.
This is a two-phase prospective clinical study evaluating the performance and safety of the investigational MRI device for neonates and infants, including:
- Phase 1 - Initial feasibility assessment and optimization study (Phase 1) which may include hardware and software modifications. These studies are guided by a series of MR scanning procedures defined in sequential Sponsor-provided MR Procedure Documents
- Phase 2 - Controlled image and data collection study based on Phase 1 results, in which optimized scan procedure(s) according to MR Procedure Document(s) will be provided at the start of Phase 2 scanning and a fixed hardware and integrated software configuration will be applied for all subjects.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Subjects will be included that are:
- Currently admitted for treatment or observation at the investigational site at the time of enrollment;
- In the weight range less than 5.0 kg (<5.0 kg ) and more than 0.5 kg (>0.5 kg );
- Viable neonates (birth to 1 month of age) or infants (>1 month to two years of age);
- Able to safely undergo an MRI scan, as determined by the site's co-investigator neonatologist or medically qualified delegate;
- Have parent(s), guardian(s), or legally authorized representative(s) willing and able to provide written informed consent for the subject's participation;
Are of appropriate size and shape to fit into the bore of the magnet, inclusive of all monitoring equipment, if any, necessary for the subject's routine clinical care:
- Maximum width (shoulder-to-shoulder measurement) less than eighteen (18 cm).
- Maximum length (head-to-foot measurement) less than sixty (60) cm. -
Exclusion Criteria:
Subjects will be excluded that:
- Have parent(s), guardian(s), or legally authorized representative(s) that require that they accompany the subject into the MR environment that have contraindications to the MR environment or would otherwise be put at undue risk or discomfort, as determined by the investigators;
- Require any non-removable medical devices that are not compatible with MR scanning (labeled as MR Unsafe, MR condition for which the scanning conditions are not met, or no MR safety labeling) that may pose hazards in the MR scanning or MR environment, in the opinion of the neonatologist co-investigator or medically qualified delegate;
- Have other contraindications or could otherwise be expected to experience detrimental effects to safety, well-being, or medical care, as determined by the neonatologist co-investigator;
- Require any scheduled standard of care procedures that are expected to be adversely impacted by participation in this study, in the opinion of the principal investigator, neonatologist co-investigator, or medically qualified delegate; and
- Have been previously enrolled AND undergone any study procedures under the current study protocol (i.e. the same subject cannot undergo study procedures, including swaddling and/or MR scanning, more than once).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 3.0 T Neonatal Scanner
All subjects who participate in this study will be scanned using the 3.0 T Neonatal MRI scanner.
|
Eligible subjects will undergo neonatal MRI scanning procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Summary Rates of Adverse Events
Time Frame: 1 Day
|
Safety will be assessed based on the number of Adverse Events.
|
1 Day
|
Image Diagnostic Quality
Time Frame: 1 Day
|
Number of subject whose images were rated as Evaluable
|
1 Day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI Scan Time
Time Frame: 1 Day
|
Duration of MRI scan time for each subject
|
1 Day
|
Overall Experience With Neonatal MR Scanner Device Summary
Time Frame: 1 day
|
User survey results on a scale from 1 to 5, where 1 = strongly disagree and 5 = strongly agree.
|
1 day
|
Overall Image Quality
Time Frame: 1 day
|
Scores range from 1-Very Poor image quality to 5-Excellent image quality.
|
1 day
|
Subject Change in Temperature
Time Frame: 1 Day
|
Change in temperature (Celsius) per subject.
|
1 Day
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Image Evaluation
-
Toshiba America Medical Systems, Inc.CompletedObtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation.United States
-
Medical University of ViennaUnknownQuality of Life | Morbidity | Breast Image Scale Index for Self Esteem Evaluation | Breast Symmetry Index | Oncological OutcomeAustria
-
University of SheffieldCompletedBody Image Disturbance | Body Image | ShameUnited Kingdom
-
DiA Imaging Analysis LtdUnknownLeft Ventricular Function | EF Evaluation From 4 Chamber Plane | EF Evaluation From 2 Chamber Plane | Biplane EF EvaluationIsrael
-
Trakya UniversityMedipol UniversityCompleted
-
Duke UniversityTerminatedImage, BodyUnited States
-
University of the West of EnglandUnilever R&D; UNICEF; Deakin University; Talk 2 U; Instituto Federal Sudeste de Minas...Completed
-
University of the West of EnglandTata Institute of Social Sciences; Lady Shri Ram College for WomenCompleted
-
Chapman UniversityOhio State UniversityUnknown
-
Henry Ford Health SystemCompletedTEE Image QualityUnited States
Clinical Trials on 3.0 T Neonatal MRI Scanner
-
GE HealthcareWellcome TrustCompletedNeonatal NeuroimagingUnited Kingdom
-
NYU Langone HealthWithdrawnBreast Cancer | BRCA1 Mutation | BRCA2 MutationUnited States
-
M.D. Anderson Cancer CenterCompletedLiver CancerUnited States
-
Charite University, Berlin, GermanyCompleted
-
University Hospital, GrenobleUniversity Grenoble Alps; Laboratoire de Psychologie et NeuroCognition; Université...CompletedMemory, Episodic | Form PerceptionFrance
-
National Cancer Institute (NCI)RecruitingGlioma | High Grade Glioma | Malignant Glioma | Gliomas | Low Grade GliomaUnited States
-
Hopital FochTerminated
-
NHS Greater Glasgow and ClydeUniversity of GlasgowRecruitingStroke, AcuteUnited Kingdom
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Congenital Heart Disease | Acute Myocardial Infarction | Cardiomyopathy | Cardiac Magnetic Resonance ImagingUnited States
-
Max Planck Institute for Human Cognitive and Brain...Hannover Medical School; Leipzig University Medical CenterCompletedTourette Syndrome | Gilles de la Tourette SyndromeGermany